![](/img/cover-not-exists.png)
102 Identification and preclinical characterization of NMS-P626, a potent, selective and orally bioavailable TrkA inhibitor with anti-tumor activity in a TrkA-dependent colorectal cancer
E. Ardini, A. Lombardi Borgia, C. De Ponti, N. Amboldi, D. Ballinari, M.B. Saccardo, P. Magnaghi, E. Pesenti, A. Isacchi, A. GalvaniVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)71807-3
File:
PDF, 62 KB
english, 2010